(345) 949-8600

Health Services Authority

  • COVID-19 Info
  • Make a payment
  • Employee Login
  • Services & Specialties
    • Inpatient
    • Outpatient
    • Pharmacy
    • Overseas Treatment
    • Public Health
  • News & Events
  • Patients & Visitors
    • What you need to know
    • Where To Go for the Care You Need
    • Registration & Admission
    • Visitors
    • Medical Records
    • How to make a payment
    • Patient Rights & Responsibilities
    • Patient Services
    • Wheelchair Assistance
    • Pastoral Care
    • Patient Financial Services
    • Patient Feedback
    • Hurricane Preparedness
  • Employment and Training
  • Online Pharmacy

HSA cease distribution of Valsartan after recall

by Monique Spence / Friday, 10 August 2018 / Published in News

 

The Cayman Islands Health Services Authority (HSA) has immediately ceased the distribution of the generic medication valsartan, which is used to treat high blood pressure and heart failure due to an impurity discovered in the products and a recall issued by the United States Food and Drug Administration and The European Medicines Agency.

As part of its proactive approach, the Authority is contacting all its patients who are currently prescribed the medication to provide a recommended alternative. Those who have not received a call should contact the HSA at 345-916-8301.

Deputy Medical Director, Dr. Courtney Cummings says the quick action by the HSA, is part of its robust quality control initiatives in actively monitoring and responding to all alerts to ensure the safety and highest standards of pharmaceuticals dispensed to patients. “This is also why we maintain a high level of vigilance in the monitoring, sourcing and dispensing of all pharmaceuticals to protect our patients.”

Dr Cummings emphasizes that at present the Authority has not received any reports of adverse events related to this recall.

Patients in the private sector prescribed the medication should contact their pharmacist or physician who can advise them about an alternative treatment.

The US FDA advises that patients who are on valsartan should continue taking their medication, until an alternative is prescribed by their physician, as the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment.

  • Tweet

What you can read next

Little Cayman receives first purpose-built ambulance
Free HIV & STI testing available for World AIDS Day 2021
Flu vaccine now available

Search

Archive

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

Public Health Archive

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Our Locations

  • Cayman Islands Hospital
  • Faith Hospital
  • Little Cayman Clinic
  • District Health Centres
  • Merren Dental Clinic
  • Lions Eye Clinic
  • Smith Road Medical Centre
  • Bay Town House

GET IN THE KNOW

  • About HSA
  • Contact Us
  • Message from the CEO
  • Organizational Structure
  • Our Mission
  • Governing Laws
  • FOI – Freedom of Information
  • Media Policy

Our Locations

  • Cayman Islands Hospital
  • Faith Hospital
  • Smith Road Medical Centre
  • District Health Centres
  • Lions Eye Clinic
  • Merren Dental Clinic
  • Bay Town House
  • Little Cayman Clinic

Additional Services

  • Cancer Registry
  • Cayman Islands Blood Bank

Specialties & Services

  • Inpatient
  • Outpatient

I would like to ...

  • Find A Physician
  • Apply for a job
  • Volunteer
  • Make a payment
  • Patient Financial Services
   © 2023 HSA.KY All rights reserved. | P.O. Box 915 GT Grand Cayman Cayman Islands
  • Site Map
  • Privacy Notice
  • Terms of Use
  • Contact Us
  • COVID-19 Info
  • Employee Login
  • Media Policy
  • MyHSA Patient Portal
TOP